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In this work, the proteinase activity detect in the acetone precipitate (80%, v/v) of B. forﬁcata leaves,
trivially known as cow paw, and popularly used in folk medicine for treatment of diabetes mellitus, was
puriﬁed by chromatography on Sephadex G-25, Canecystatin-Sepharose, and on Con A-Sepharose. The
molecular weight 30kDa was estimated by SDS-PAGE and zymography, and the N-terminal sequence
and CD spectra indicated a relationship with the papain family of cysteine proteinases. Denominated
baupain, the enzyme was activated by dithiotreitol and inhibited by E-64 and iodoacetamide, but notircular dichroism
ysteine proteinase
apain
lant enzyme
rotein puriﬁcation
ubstrate speciﬁcity
by benzamidine, TLCK, TPCK and EDTA. The S2 and S1 substrate speciﬁcity of baupain, assayed with two
series of ﬂuorescence resonance energy transfer (FRET) peptide substrates derived from Abz-KLRSSK-Q-
EDDnp, indicates a preference for Phe and Tyr at P2 position over Leu found in papain. Baupain releases
bradykinin from HMWK (human high molecular weight kininogen) though its proteolytic activity is
blocked by the sequence motif QVVA of kininogen (Kiapp = 1.9×10−8 M). Canecystatin, from sugar cane,
which also lodges the QVVA sequence, inhibits baupain (Kiapp = 0.18×10−9 M).. Introduction
Within the members of cysteine proteinases expressed in
iruses, bacteria, animals and plants [1], papain is the archetypical
ember of these endopeptidyl hydrolases (EC 3.4.22). This group
lso comprise the mammalian lysosomal cathepsins, the cytoso-
ic calpains (i.e., calcium activated cysteine proteinases) as well as
everal parasitic proteinases [2,3].
The action of these enzymes can be controlled by members
f a family known as cystatins super family, which comprises
hree families, on the basis of sub-cellular localization, molecu-
ar weight, disulﬁde bonds and sequence similarity including the
XVXG motif. Speciﬁcally from plant, this group is known as plant
ystatins or phytocystatins (PhyCys) whose primary sequences
Abbreviations: FRET, ﬂuorescence resonance energy transfer; Q-EDD,
pglutaminyl-[N-(2,4-dinitrophenyl)-ethylenediamine]; Abz, ortho-aminobenzoic
cid; HPLC, high performance liquid chromatography; LC/MS, liquid chromatogra-
hy/mass spectrometry.
∗ Corresponding author at: Universidade Federal de São Paulo, Departamento de
ioquímica, Rua Três de Maio 100, 04044-020 São Paulo, SP, Brazil.
el.: +55 11 55764444; fax: +55 11 55723006.
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share a high degree of similarity within the cystatin family, includ-
ing the sequence motif QXVXG [4,5].
In plants, cysteine proteinases are widely distributed in various
tissues, and are involved in physiological events such as germina-
tion, senescence and environmental stress responses. Papain-like
cysteine proteinases are often found in senescing organs partic-
ularly leaves [6–8], ﬂowers [9], legume nodules [10] as well as
in germinating seeds [10–13]. Cysteine proteinases have been
intensively studied with various expression patterns, reported for
different stages of plant development [14–16]. Equally studied is
cysteine proteinases role in processing and degradation of seed
storage proteins [17,18], in legume nodule development [19], in
response to stresses such as wounding, cold, and drought [20] as
well as in programmed cell death [21,22].
In the present work, the puriﬁcation and the functional charac-
terization of a new cysteine proteinase from B. forﬁcata leaves are
described. B. forﬁcata is a Leguminosae known as cow paw, due to
the characteristic bilobed aspect of its leaves fromwhich the home-
Open access under the Elsevier OA license.made extract is prepared and used in popular therapy for diabetes
mellitus. The studies reported that the beneﬁcial of leaf extracts
(aqueous and alcoholic) in the prevention of diabetes complica-
tions is associated with oxidative stress since B. forﬁcata and other
plant extracts have signiﬁcant antioxidant activity [23,24].
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Although this plant has been the subject of several studies
24–26], but a characterization of the enzyme activity is not yet
escribed.
The substrate speciﬁcity of the enzyme, designated as baupain
as assayedusingpeptidesderived fromthe leading sequenceAbz-
LRSSKQEDDnp [27–31] and the series Abz-KXRSSKQ-EDDnp and
bz-KLXSSKQ-EDDnp (X=different amino acids) used formapping,
espectively, the S2 and S1 substrate speciﬁcity [29–31]. To fur-
her compare the hydrolytic properties of baupain with papain and
uman cathepsin L, we explored in vitro the ability of baupain to
elease kinin from HMWK.
. Materials and methods
.1. Enzyme puriﬁcation
Leaves (50g) collected from wild Bauhinia forﬁcata trees were homogenized in
blender with 0.15M NaCl (700ml). The proteins in the crude extract were pre-
ipitated by 80% (v/v) acetone at 4 ◦C. The sediment separated by centrifugation
as dried at room temperature, and dissolved in 0.1M sodium phosphate buffer,
H 6.3. The enzyme fraction (1.5ml) was applied on a size exclusion chromatogra-
hy (Sephadex G-25) equilibrated with 0.1M sodium phosphate buffer, pH 6.3. The
nzyme activity was followed using Z–Phe–Arg–MCA as substrate. The fractions
ontaining enzyme activity were pooled and subsequently chromatographed on a
anecystatin-Sepharose, equilibrated with the same phosphate buffer. The active
aterial, eluted by 2.0mM l-cysteine, was chromatographed on Con A Sepharose,
quilibrated with 0.1M sodium phosphate buffer, pH 6.3, used for removal of pig-
ents. The whole puriﬁcation procedure was carried out at 4 ◦C. The unbound
ractions containing enzyme activity were separated and subsequently puriﬁed by
PLCona-BondapakC18 reversephase column. The separationwas achievedbyan
cetonitrile gradient (0–100%) in 0.1% TFA (v/v) during 75min, at 1ml/min ﬂow rate
nd room temperature. Proteins were estimated spectrophotometrically (A280) as
ell as by Bradford [32] assay using bovine serum albumin as the standard.
.2. N-terminal amino acid sequence
Puriﬁed baupain was denatured and reduced by addition of 200l 50mM
ris/HCl buffer, pH 8.5, containing 6.0M guadinium HCl, 1.0mM EDTA, and 5.0mM
ithiothreitol for 3h, at 37 ◦C. S-pyridylethylation of cysteineswas achievedby addi-
ion of (5l) 4-vinylpyrimidine for 3h at 37 ◦C in the dark and nitrogen atmosphere.
he excess reagents were removed by reversed-phase HPLC on a C18 column using
he same gradient conditions already described. N-terminal amino acid sequences
ere determined by Edman degradation using a PPSQ-23 Model Protein Sequencer
Shimadzu, Tokyo, Japan). Phenylthiohydantoin derivates of amino acidswere iden-
iﬁed.
.3. Electrophoresis and gelatin zymography
The homogeneity and the molecular weight of baupain were assessed by SDS-
AGE under reducing and non-reducing conditions according to Laemmli [33],
sing 12% acrylamide gel. HMWK (10g) limited proteolysis cleavage by baupain
0.23M) was demonstrated by SDS-polyacrylamide gel electrophoresis [34]. Bau-
ain and HMWK were incubated in 0.1M sodium phosphate buffer, pH 6.3 for 10
nd 60min at 37 ◦C. The proteins were stained with Coomassie brilliant blue R-250.
broad range of molecular weight protein markers, from 25 to 175kDa and 20 to
4kDa New England BioLabs Inc. (Ipswich, MA, USA), was used.
The zymography experiment was performance under non-reducing conditions
ccording to Becker et al. [35]. Baupain activity was detected using 10% (w/v) acry-
amide (Gelatin-PAGE), with 0.04% (w/v) copolymerized gelatin included in the gel
s substrate for the proteinase. After electrophoresis, the gels were incubated in
enaturing buffer for 1h at room temperature, followed with incubation in devel-
ping buffer at 37 ◦C overnight. We used Mini-Protean® II Cell Bio-Rad (Hercules,
A, USA).
.4. Enzyme activity
Proteinase activity was measured on Z–Phe–Arg–MCA (Calbiochem Ltda, Darm-
tadt, Germany) and Bz-Arg-pNan (BAPA) (Sigma–Aldrich Company, St. Louis, USA)
s substrates. Baupain was incubated at 37 ◦C in a microtiter plate in 250l ﬁnal
olume of assay buffer [0.1M sodium phosphate buffer, pH 6.3 containing 0.4M
aCl, 10mM EDTA, and 2.0mM DTT (dithiothreitol)]. The reaction was followedor 10–30min and the reaction was stopped by the addition of 50l acetic acid
0% (v/v). The ﬂuorescence release was measured on a FluoroCount PackardTM,
pectroﬂuorometer set at 355nm for excitation and 460nm for emission.
In the case of BAPA (0.8mM) as substrate, the reaction was followed by mea-
uring the absorbance of released p-nitroaniline at 405nm in a spectrophotometer
ackardTM with a 50mM Tris/HCl buffer, pH 8.0 [36].mistry 46 (2011) 572–578 573
2.5. Effects of activators on enzyme activity
Baupain (0.23M) was preincubated with DTT, -mercaptoethanol, and l-
cysteine (2mM) in 0.1M sodium phosphate buffer, pH 6.3 containing 0.4M NaCl,
10mM EDTA, at 37 ◦C for 30min. The enzyme activity was determined as described,
using Z–Phe–Arg–MCA (0.4mM) as substrate.
2.6. Effect of pH on the enzyme activity
Prior to the addition of the substrate Z–Phe–Arg–MCA 40l of baupain
(0.23M) was pre-incubated at 37 ◦C for 30min with 100l of the following buffer
systems: 0.2M sodium citrate, pH 4.0; 0.2M sodium acetate, pH 5.0; 0.2M sodium
phosphate, pH 6.0; 0.2M Tris/HCl, pH 7.0 and pH 8.0 and 0.2M sodium bicarbonate,
pH 9.0 and pH 10.0 in a ﬁnal volume of 250l by adding 90l of distillated water.
The enzymatic activity was measured using 20l of Z–Phe–Arg–MCA (5mM) as
substrate.
2.7. Proteinase inhibition studies
Effect of low molecular weight inhibitors: Baupain (0.23M) was incu-
batedwith 1.0ME-64 (l-trans-epoxysuccinyl-leucylamido [4-guanidino] butane),
1.0mM benzamidine, 2.0mM phenylmethanesulfonyl ﬂuoride (PMSF), 2.0mM
ortho-phenantroline, 5.0mM ethylenediamine tetraacetic acid (EDTA), 1.0mM
N-tosyl-l-phenylalanylchloromethyl ketone (TPCK), and 1.0mM N-tosyl-l-lysyl
chloromethyl ketone (TLCK), for 10min at 37 ◦C, before the addition of the substrate
Z–Phe–Arg–MCA (0.4mM). The assay concentration of each inhibitor was chosen
based in suppliers information and inhibitor mode of action [37]. Enzyme activity
was expressed in percent of residual activity on Z–Phe–Arg–MCA compared to the
control.
Effect of high molecular weight (proteinaceus) inhibitors: baupain (0.23M)
was pre-incubated for 10min in assay buffer with the serine proteinase inhibitors
SbTI (Soy beans trypsin inhibitor) [38] 1.39, 2.78, 5.56, 8.35M; EcTI (Enterolobium
contortisiliquum trypsin inhibitor) [39] 0.2, 0.7, 1.50, 2.0, 2.7M and with the cys-
teine proteinase inhibitors HMWK (High Molecular Weight Kininogen) 0.08, 0.16,
0.24, and 0.32M; canecystatin [5] 0.06, 0.12, 0.18, 0.24 and 0.34nM and BbCI
(Bauhinia bauhinioides cruzain inhibitor) [40] 1.2, 1.8, 2.4, 3.6, and 4.8M. Enzyme
activity was expressed in percent of residual activity on Z–Phe–Arg–MCA compared
to the control.
2.8. Determination of baupain substrate speciﬁcity
The hydrolysis of two series of FRET peptides derived from Abz-KLRSSK-Q-
EDDnp (Q-EDDnp is the ﬂuorescence acceptor and Abz is the ﬂuorescence donor
that corresponds toglutamine-[N-(2,4-dinitrophenyl)-ethylenediamine] andortho-
aminobenzoic acid, respectively), in which the residues L and R and S were
substituted by natural amino acids were quantiﬁed in a Hitachi F-2500 spectroﬂu-
orimeter at 37 ◦C. Baupain concentration was ﬁxed as 11nM and the substrates
as 4M. Fluorescence changes were monitored continuously at ex = 320nm and
em =420nm. The enzyme concentrations were chosen so that less than 5% of the
substrate was hydrolyzed over the course of the assay. The reaction rate was con-
verted into nanomoles of substrate hydrolyzed per second based on a calibration
curve obtained from the complete hydrolysis of each peptide. The scissile bond of
hydrolyzed peptides were identiﬁed by isolation of the fragments using analyti-
cal HPLC followed by determination of their molecular mass by LC/MS using an
LCMS-2010 equipped with an ESI-probe (Shimadzu, Japan).
2.9. CD experiments
Circular Dichroism (CD) measurements were taken on a Jasco J-810 spectropo-
larimeter (Jasco, Japan). Far UV-CD spectra were recorded at 25 ◦C in a cuvette of
1mm pathlength with a 10M protein solution in the presence of 10mM sodium
phosphate buffer, pH 6.3. The spectra were recorded in the 190–250nm wave-
length range. The CD intensities were expressed as mean residue ellipiticities []
(deg cm2 dmol−1) using the formula [] = e/10.C.l.N, where e is the experimental
ellipticity in millidegrees, MRW is the mean residue weight, C is the concentration
of the protein in molar, l is the cuvette pathlength in centimeters, and N being the
average number of residues adopted as 110 residues baupain. For the analysis of
baupain CD spectrum the CDPro program was used. CDPro software package con-
sists of three programs for analyzing the protein CD spectra for determining the
secondary structure fractions (SELCON3, CDSSTR and CONTIN) and a program for
determining tertiary structure class (CLUSTER) [41,42]. The estimation of baupain
secondary structure was performance using 43 proteins in the reference set.2.10. Fluorescence experiments
Steady-state ﬂuorescence was recorded on Hitachi F-2500 spectroﬂuorimeter.
Intrinsic tryptophan ﬂuorescence spectrum was recorded by exciting the protein
sampleat290nmatpH6.3, 10mMsodiumphosphatebuffer. Theemission spectrum
was recorded in the range of 305–450nm with excitation and emission slit widths
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Fig. 1. Size exclusion chromatography on Sephadex G-25 column of B. forﬁ-
cate leaves extract. Eluting buffer: 0.1M sodium phosphate buffer, pH 6.3. Flow
rate: 16ml/h. The arrow indicates activity on Z–Phe–Arg–MCA (0.4mM). Insert:
Canecystatin-Sepharose column (2mL). Sample: 0.4mg of baupain from Sephadex
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Fig. 2. (A) SDS-PAGE (12%) of the cysteine proteinase baupain from Bauhinia
forﬁcata leaves. (1) Baupain (10g) from Con A-Sepharose under reducing
conditions, Coomassie blue staining; (S), standard proteins, -lactoglobulin A
(25kDa), triosephosphate isomerase (32kDA), aldolase (47kDa, glutamic dehydro-
genase (62kDa), MBP-paramyosin (83kDa) and MBP--galactosidase (175kDa).
(B) Gelatin-PAGE proteinase activity analysis of baupain 10g (1), and 20g (2).
Clear band with dark background indicate sites of protein degradation in 10%-25 column. (A) Unbound fractions were eluted with 0.1M sodium phosphate
uffer, pH 6.3 buffer. (B) The bound fraction (16) with activity on Z–Phe–Arg–MCA
ubstratewas elutedwith0.1Msodiumphosphatebuffer, pH6.3 containing0.001M
-cysteine.
et a 5.0 and 2.5nm, respectively. Baseline correction was carried out with buffer
ithout protein.
.11. Radioimmunoassay
Baupain bradykinin release ability was assayed with HMWK [43]. The enzyme,
n concentrations of 0.019, 0.038, and 0.057 A280 in 0.1M sodiumphosphate, pH 6.3
ontaining 10mM EDTA, 0.4M NaCl, and 2.0mM DTT was incubated with HMWK
1.4M) in 40l for 2h at 37 ◦C. Formed kinin was extracted in ethanol (1:4 v/v) for
0min at −70 ◦C. The solution was concentrated and dissolved in 200l of 0.01M
hosphate buffer, pH 7.0, NaCl 0.14M, NaN3, 0.03M EDTA, 0.003M 1,10 phenan-
hroline and ovalbumin 0.1%. 50l of the samplewas incubatedwith 100l anti-BK
ntibody [44] (1: 80.000) and 100l tyrosyl-bradykinin probe with 125I, for 20h at
◦C, 400l the BSA (2mg/ml) 0.01M phosphate buffer, pH 7.0, 0.1% NaCl 0.14M,
aN3 0.1% and 800l with polyethylene glycol 6000 25% solution were added to
he samples and incubated by 10min at 4 ◦C. Samples were centrifuged at 2000× g
or 20min at 4 ◦C. The solution obtained was removed and the pellet was submitted
o the radiation counting and the bradykinin released was calculated.
. Results and discussion
.1. Proteinase extraction and puriﬁcation
The protocol used for isolation and puriﬁcation of the endopro-
einase from B. forﬁcata consists of three steps. Freshly prepared
eaves saline extracts were treated with 80% acetone in order to
recipitate the protein content. The precipitate containing prote-
lytic activity was submitted to a size exclusion chromatography
n a Sephadex G-25 column (Fig. 1) and the fractions with enzyme
ctivity on Z–Phe–Arg–MCA were polled and concentrated by Ami-
on ultraﬁltration.
The strategy to apply afﬁnity chromatography with thiopropyl-
epharose have been successfully used in the cysteine proteinase
uriﬁcation since this resinpresents strongbinding2-pyridyl disul-
de [45,46]. In our case, the procedure resulted in low yield of
uriﬁcation (data not shown), probably due to the pH 6.3 used
here the interaction to the activated group is not efﬁcient. Further
uriﬁcation was obtained using a canecystatin-Sepharose column
Fig. 1, insert) being the enzyme activity detected in the broad
eak eluted with 1.0mM l-cysteine. The peak showing activity
n Z–Phe–Arg–MCA was polled, concentrated and submitted to
Concanavalin A-Sepharose afﬁnity chromatography to complete
emoval of leave pigments. Proteolytic activity was detected only
n the unbound fraction, depleted of leave pigments. The speciﬁcacrylamide and 0.04% gelatin in non-reducing conditions and incubated in 0.1M
sodiumphosphate, pH6.3 for 24h. (S) standard proteins,-lactoglobulin A (25kDa),
triosephosphate isomerase (32kDA), aldolase (47kDa, glutamic dehydrogenase
(62kDa), and MBP-paramyosin (83kDa).
activity of the endopeptidase was increased more than 79-fold by
this isolation procedure and both SDS and non-denaturing PAGE of
the ﬁnal preparation stained with Coomassie brilliant blue showed
a homogeneous preparation (data not shown). The puriﬁcation
steps are summarized in Table 1.
Themolecularweight of thepuriﬁedproteinasewasdetermined
by SDS-PAGE as 30kDa (Fig. 2). The same result was obtained by
size exclusion chromatography on calibrated Superdex-200 col-
umn, where the proteolytic activity was found essentially in the
main peak eluted with a volume that corresponds to a molecular
mass of 33±4kDa (data not shown).
3.2. N-terminal sequence
Reverse phase chromatography in a C18 column was per-
formed with acetonitrile gradient, and the N-terminal sequences
of reduced and pyridylethylated inhibitors determined by auto-
mated Edman degradation allowed the identiﬁcation of the ﬁrst
10 amino acid residues (IPEYVDWRQQ). Using NCBI database, PSI-
BLAST [47] baupain shows similarity to those of the CA family of
cysteine proteinases, being 90% and 40% identical to papain and
bromelain, respectively.
3.3. Effect of metal ions, selective inhibitors and sulfhydryl
reagents on proteinase activity
The inhibition of enzyme activity was negligible by low
molecular weight serine proteinase inhibitors PMSF, TPLC, TLCK,
benzamidine, metallo proteinase inhibitors EDTA and 1,10-
phenanthroline and aspartic proteinase inhibitor pepstatin A.
However, the activity was completely inhibited by the sulfhydryl
modifying reagent iodoacetamideandby thepapain family-speciﬁc
inhibitor E-64. Since the reducing agents (2-mercaptoethanol, DTT
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Table 1
Puriﬁcation of cysteine proteinase from B. forﬁcata.
Steps Volume (mL) Protein (mgmL) UA Speciﬁc activity (UAmg) Purif. Yield (%)
Saline extraction (50g) 700 – – – – –
Acetone fractionation (80%) 30 1.0 – – – –
Sephadex G-25 5 0.32 0.2 0.6 1.0 100
E ols of
(
b
o
3
c
C
1
t
s
T
c
o
w
t
c
(
t
C
t
3
t
m
F
p
c
bCanecystatin-Sepharose 2.2 0.48
Con A-Sepharose 1.6 0.43
nzyme activity was determined on Z–Phe–Arg–MCA 0.4mM as substrate. UA –m
dithiothreitol) and l-cysteine) enhanced the hydrolytic activity of
aupain (data not shown), all further assays where performed with
f 2.0mM DTT.
.4. Circular dicroism spectra
The tertiary structure of the enzyme was assessed by far UV
ircular dichroism. The CD spectrum (Fig. 3) shows two negative
D bands at 222nm and 208–210nm and one positive band near
90nm. The cluster analysis showed that the peptidase belongs to
he + class of proteins [48] and the percentages of secondary
tructure, calculated as 44% -helix, 16% -sheet and 12% -turn.
hese data are consistent with the reported data on papain like
ysteine proteinases [2].
The intrinsic ﬂuorescence spectra of the proteinase was
btained at pH 7.0 and the maximum of ﬂuorescence intensity
as observed at 343nm, a value characteristic of solvent accessible
ryptophan residues. This data is in agreement with the ﬂuores-
ence emission maximum value of 345nm obtained with papain
data not shown) [49,50]. All together, these results suggest that
he enzyme belongs to the group of cysteine proteinases of the clan
A of the papain family, and the name baupain was proposed for
his new endopeptidase..5. Proteolytic activity characterization
The baupain hydrolytic activity remains after preincubation of
he enzyme at different pH values in the range of 4.5–9 for 30-
in at 37 ◦C. In the same experiments performed in the pH range
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ig. 3. CD spectrum of baupain (0.05mg/ml), in 0.001M sodium phosphate buffer,
H 7.0. The spectrum was recorded over the range 190–250nm, at 25 ◦C, in 1mm
ell pathlength. CD Pro program was used for estimation of secondary structure of
aupain. The calculated fractions were 44% -helix, 16% -sheet and 12% -turn.0.4 0.8 2.0 88
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Z–Phe–Arg–MCA hydrolyzed/minmL. Protein determinated by Bradford [32] assay.
3–4.5 and 9–10 the enzyme became irreversibly inactivated (data
not shown).
The pH-proﬁle of the hydrolytic activity of baupain on
Z–Phe–Arg–MCA was measured in the pH range from 4 to 10
(Fig. 4A). The baupain maximum activity was achieved at pH 6.0
and very low activity observed at extreme acid and basic pHs sim-
ilar to that obtained with papain like cysteine proteinases [4], we
used the following assay buffer for further kinetic studies: 0.1M
sodium phosphate buffer, pH 6.3 containing 10mM EDTA, 0.4M
NaCl, and 2.0mM DTT.
3.6. Substrate speciﬁcity of baupain using FRET substrates
Seven residues intramolecularly quenched ﬂuorogenic Abz-
peptidyl-EDDnp substrates, containing systematic substitutions at
the carboxyl-side of the scissile bond, were used to evaluate the
contribution of these positions in baupain substrates hydrolytic
rate. Two series of peptides were generated with variations at P2
and P1 positions to explore the speciﬁcity at the S2 and S1 subsites
that usually deﬁne substrate speciﬁcity amongpapain-like cysteine
proteinases [51].
3.6.1. Hydrolysis of Abz-KLXSSKQ-EDDnp series, for mapping S1
speciﬁcity
Fig. 5A shows the baupain relative hydrolysis of the peptide
series Abz-KLXSSKQ-EDDnp with different amino acids at X posi-
tion. All substrates in this series were cleaved only at the X-Ser
bond, indicating that X occupied the P1 position. Baupain did not
present a deﬁned speciﬁcity over the assayed peptides, being the
peptide containing Gly at P1 hydrolyzed at the same rate as the
one containing Phe and Arg. Deviations were observed only with
the peptides containing negatively charged residues (Glu and Asp)
and the bulky Trp. This apparent lack of speciﬁcity at S1 contrasts
Fig. 4. pH proﬁle for baupain hydrolytic activity. Initial activity of hydrolysis of
Z–Phe–Arg–MCA was carried out as described in Section 2. The relative values were
obtained assessing the highest value as 100%. The curve drawn through the exper-
imental points was obtained from ﬁtting to the appropriated equation using the
Graﬁt 5.0 software (Erithacus Software, Orley, Surrey, U.K.).
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was quantiﬁed by radioimmunoassay (Fig. 7A). This activity was
abolished by the addition of the irreversible cysteine proteinase
inhibitor E-64, demonstrating the speciﬁcity of assay. Baupain
cleavage of HMWK generates one major band of 45kDa and that
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 M ig. 5. (A) Baupain S1 substrate speciﬁcity. All substrates in this series were cleave
onditions are as described in Section 2. (B) Baupain S2 substrate speciﬁcity. All s
ccupying the P2 position. (C) Baupain activity on Z–Phe–Arg–MCA and Z-Leu-Arg-
ith that of papain, bromelain and human cathepsin L that show a
reference for basic amino acids in P1 [29,51].
.6.2. Hydrolysis of Abz-KXRSSKQ-EDDnp series, for mapping S2
peciﬁcity
The relative hydrolysis of the peptide series Abz-KXRSSKQ-
DDnp is shown in Fig. 5B. All peptides from this series, under the
ssay conditions used, were exclusively cleaved by the enzyme at
heArg-SerbondwithXoccupyingP2position. Thebesthydrolyzed
eptides were those containing Tyr or Phe at P2 position, whereas
hose containing positively or negatively charged amino acids (Arg,
ys, His and Asp) as well as polar groups (Ser, Thr) were poorly
ydrolyzed. It is interesting to observe that FRET substrates having
liphatic amino acids Val and Leu were hydrolyzed with 50% and
0% of the efﬁciency obtained with the larger aromatic residues.
his preference was corroborated by higher hydrolytic efﬁciency
f baupain over Z–Phe–Arg–MCA, in comparison to Z-Leu-Arg-MCA
Fig. 5C). In this sense, baupain speciﬁcity differs from papain, that
refers Leu and Val at P2 and from bromelain, that accepts Arg at
his position [51] but is similar to human cathepsin L and V pro-
einases (as well as cruzain and L. mexicana cathepsin L) that also
refers aromatic to aliphatic amino acids interacting at S2 subsite
2,29,51].
.7. Effect of proteinaceus peptidase inhibitors on baupain
ctivity
Inhibitors from the Bowman–Birk and plant Kunitz-type family
ave been characterized by proteinase speciﬁcity, primary struc-
ureand reactive site residues [52]. Since theypresentdifferences in
roteinase inhibition proﬁles, they are valuable tolls for proteolytic
nzyme characterization. In this sense, the distinctive substrate
reference observed with baupain was further studied accessing
he effect of both plant and mammals proteinaceous peptidase
nhibitors on its hydrolytic activity.
Plant Kunitz type inhibitors STI (Soybean trypsin inhibitor) and
cTI (Enterolobium contortisiliquum trypsin inhibitor), as well as
he cysteine proteinase inhibitor isolated from Bauhinia bauhin-
oides (BbCI) do not inhibit baupain at the assayed concentrations
0.005–0.5M). While the absence of inhibition observed with
oth trypsin like inhibitors would be a expected feature due to
aupain cysteine proteinase nature, it is interesting to observe
hat BbCI does inhibits cathepsin L, cruzain and cruzipain, but it
lso fails to inhibit papain [40], sustaining a close relationship
etween both enzymes. Canecystatin, a recombinant cysteine pro-
einase inhibitor from sugar cane, efﬁciently inhibits baupain (Kiapp
0−8 M) as well as papain (Kiapp = 3.3×10−9 M) and cathepsin L
Kiapp = 0.6×10−9 M) but no inhibitory effect was observed on ﬁcin
r bromelain [53].at the X-Ser bonds, indicating that X occupied the P1 position in this series. Assay
tes of this series were exclusively cleaved by the enzyme at the R–S bond with X
s included for comparison. Assay conditions are as described in Section 2.
As observed with papain [54], a strong inhibition of baupain
(Kiapp = 1.9×10−8 M) was also obtained with human high molec-
ular weight kininogen (HMWK) (Fig. 6), a plasma multifunctional
glycoprotein that besides their role as precursor of the vasoactive
peptides kinin, posses the sequence motif QXVXG in cysteine pro-
teinase inhibitor domains [55] that is reported to inhibit cysteine
proteinases papain family [4]. Is worth to point out to the fact that
canecystatin, a baupain inhibitor also encompass the conservative
QXVXG motif in contrast to BbCI which does not affect the enzyme
activity.
3.8. Baupain kininogenase activity
The kininogenase activity of some plant cysteine proteinases
(papain, ﬁcin and bromelain) on human plasma was long ago
reported by Prado [56], more recently this characteristic was
reported for cathepsin L but not for cathepsin B. The kininogenase
activity of cathepsin L was reinforce by the release of bradykinin
from HMWK [57] and also from synthetic bradykinin-containing
fragment of kininogen [58]. This property was also detected for
baupain. The baupain kininogenase activity was observed using
stoichiometric amounts of enzymeandkininogen. Thekinin release HMWK (uM)
Fig. 6. Inhibition effect of HMWK on bapain activity. Effect of increasing concentra-
tions of HMWKon proteolytic activity towards Z-Phe-Arg-MCA (0.4mM) of baupain
in 0.1M sodium phosphate buffer, pH 6.3 containing 10mM EDTA, 0.4M NaCl, and
2.0mM DTT, and were pre-incubated for 20min at 37 ◦C.
S.S. Andrade et al. / Process Biochemistry 46 (2011) 572–578 577
Fig. 7. (A) Effect of baupain on bradykinin release. Bradykinin levels were determined by radioimmunoassay [44] in triplicate determinatives. (B) Degradation of HMWK
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[10g) by baupain (0.23M) demonstrated by SDS-PAGE 12%. (S) Standard rang
hosphate buffer, pH 6.3, containing l-cysteine 2mM. (B) Control HMWK in 0.1M
7 ◦C. (D) Baupain and HMWK incubated for 60min at 37 ◦C. (E) DTT reduced HMW
ydrolysis proﬁle is not modiﬁed in the period of 10 at 60min of
ncubation (Fig. 7B), probably by the impairment of the enzyme
ctivity by the HMWK cysteine proteinase inhibitor domains. It is
orth to emphasize that this impairment was not observed using
ther proteinaceous substrate such as insulin B-chain and the ser-
ne proteinase inhibitor isolated from the seeds of Bauhinia forﬁcata
BfTI) (data not shown). As baupain digests proteins effectively and
apidly yielding numerous proteolytic fragments, suggesting that
aupain is involved in endogenous protein degradation.
Bradykinin excised from HMWK requires the cleavage of
he . . .MK-R. . . and . . .FR-S. . . bonds at the N- and C-terminal
radykinin insertion sites, respectively. In this sense, while bau-
ain speciﬁcity data support both cleavages (Phe and Met were
ccepted at P2; Lys and Arg at P1; Ser at Pıˇ1 – Fig. 5), the kinino-
enase activity data indicate that baupain also accepts Arg at Pıˇ1,
s observed with cathepsin L [59].
These results provide structural and biochemical information
n the cysteine proteinase isolated from the leaves of B. forﬁcata
hich is utilized in popular therapy for diabetes mellitus. Bau-
ain is similar to other cathepsins and closer to cathepsin L shown
o be essential for the development of type I diabetes in non-
bese diabetic mice [60]. Indeed, it is important to consider the
ininogenase activity of baupain that releases bradykinin (BK) from
MWK. Bradykinin modulates the release of insulin in vivo [61,62]
nd the stimulation of insulin secretionbybeta cells occurs through
ctivation of B2 receptor [63,64]. These results were conﬁrmed
sing kininogen-deﬁcient rats in which the release of insulin stim-
lated by glucose administration was lower than in normal rats
65–68]. Our results suggest that the kininogenase activity of bau-
ain may be involved in the hypoglycemic property of Bauhinia
orﬁcata leaves. However, further studies are necessary to demon-
trate the effectiveness of baupain in diabetes.
. Conclusion
Byacetoneprecipitationanddifferent chromatographic steps an
ndoproteinase named baupain detected in the B. forﬁcata leaves
as puriﬁed to homogeneity. While the N-terminal sequence sim-
larity, molecular mass, circular dicroism spectra and intrinsic
uorescences proﬁles points to a close structural relationship to
apain, its activity on FRET and MCA peptides indicates substrate
peciﬁcitymore related to themammalian cathepsin L enzyme. The
[
[olecular weight protein markers 20–94kDa. (A) Control HMWK in 0.1M sodium
m phosphate buffer, pH 6.3. (C) Baupain and HMWK were incubated for 10min at
proteinase also shares with cathepsin L and papain the capacity of
releasing bradykinin from HMWK.
In conclusion, this work point out the kininogenase activity
speciﬁcity proﬁle of baupain that is distinct from other cysteine
proteinases and similar to cathepsin L [57]. We believe that this
property may be relevant to regroup cluster papain-like cysteine
proteinases.
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